Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for BioCryst Pharma (BCRX): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
14 analysts
Options Flow (P/C)
0.09
More calls — Bullish
Avg Consensus PT
$21
+154.1%
Highest Price Target
$32
+292.6%
Lowest Price Target
$9
+10.4%
Short Interest
13.8%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | JP Morgan | Jessica Fye— | +59.5% | $12 → $13 | Maintained | Neutral |
| Sep 10, 2026 | RBC Capital | Brian Abrahams— | +35.0% | $13 → $11 | Downgrade | Outperform→Sector Perform |